Mouse Anti-Human TRAIL/Apo2L
Slide this table
| Cat-Nr. | 101-M86 |
| Size | 500 µg |
| Price | 275 € |
| Category | Monoclonal Antibody |
| Isotype | IgG1, kappa |
| Species Reactivity | Human |
| Formulation | lyophilized from PBS |
| Buffer | PBS |
| Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
| Stability and Storage | The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C. |
| Preparation | Produced in BALB/c x ICR F1 mice using highly pure (>98%) recombinant human TRAIL/APO2L as the immunizing antigen. This IgG1K antibody was purified from ascites fluid by Protein A affinity chromatography. |
| Antigen | Recombinant human TRAIL/ApoL2 |
| Application | ELISA |
| Synonyms | TNFSF10; TL2; APO2L; CD253; TRAIL; Apo-2L |
| Description | TNF-related apoptosis-inducing ligand (TRAIL) is a ligand molecule which induces apoptosis. It is a type II transmembrane protein with homology to other members of the tumor necrosis factor family. In humans, the gene that encodes for TRAIL is located at chromosome 3q26. TRAIL binds to the death receptors, DR4 and DR5. The process of apoptosis is caspase-8-dependent. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. |
| Uniprot ID | P50591 |
| Protein RefSeq | NP_003801.1 |
| mRNA RefSeq | NM_003810.3 |
All prices plus VAT + possible delivery charges